Sales executives grapple with lackluster sales

Published: 2013-05-16 06:56:00

Updated: 2013-05-16 06:56:00

Pharmaceutical companies, large or small, are continuing to grapple with a low growth in the first quarter of the year due largely to sluggish sales in the domestic market, according to Yakup.com, a pharmaceutical information portal on Wednesday.

Despite a wide range of promotion steps to boos...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK